Dyax DX-88 Anticipated Approval Pushed Back to 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
Company will conduct a confirmatory placebo-controlled trial following FDA recommendation.
You may also be interested in...
Dyax Launches Confirmatory DX-88 Study Requested By FDA
Late 2008 approval for the experimental hereditary angioedema treatment is anticipated.
Dyax Launches Confirmatory DX-88 Study Requested By FDA
Late 2008 approval for the experimental hereditary angioedema treatment is anticipated.
Dyax Loses Genzyme As DX-88 Partner, But Still Eyes 2008 Approval
Firm is yet to make a decision on whether it will find new partner or continue development on its own.